Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 951-975 of 2409. (97 Page(s) Totally) << < 34 35 36 37 38 39 40 41 42 43 > >> View [10|25|50] records per page

Date	Title	Relation
2017-03	Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells	Oncogene. 2017 Mar;36(11):1503-1515.
2017-03	Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line TKIs	American Journal of Respiratory and Critical Care Medicine. 2017 Mar;195(5):663-673.
2017-03	Clinical outcomes of Taiwanese patients with cT4 oral cavity squamous cell carcinoma: Toward the identification of the optimal initial treatment approach for cT4b patients	Annals of Surgical Oncology. 2017 Mar;24(3):785-793.
2017-03	Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene	Radiotherapy and Oncology. 2017 Mar;122(3):476-484.
2017-03	PLCB4 copy gain and PLCss4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival	Oncotarget. 2017 Mar;8(12):19997-20010.
2017-03	Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-kappaB signaling	Oncotarget. 2017 Mar;8(13):20706-20718.
2017-02-28	The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels	International Journal of Clinical and Experimental Medicine. 2017 Frb 28;10(2):3162-3168.
2017-02-23	Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells	Cell Death and Disease. 2017 Feb 23;8(2):Article number e2626.
2017-02	Nanoliposomal irinotecan in the clinical practice guideline for metastatic pancreatic cancer: Applicability to clinical situations	Journal of Clinical Oncology. 2017 Feb;35(6):689-690.
2017-02	The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21)	Journal of Pathology. 2017 Feb;241(3):420-433.
2017-02	Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma	European Journal of Cancer. 2017 Feb;72:226-234.
2017-02	Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells	Oncology Reports. 2017 Feb;37(2):969-978.
2017-02	Down-regulation of RASA1 is associated with poor prognosis in human hepatocellular carcinoma	Anticancer Research. 2017 Feb;37(2):781-785.
2017-02	A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer	Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):417.
2017-02	Efficacy and safety of liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) who previously received gemcitabine (gem)-based therapy: Post-hoc analysis of the NAPO	Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):303.
2017-02	Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial	Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):2.
2017-02	Characteristics of long-term survivors in a randomized phase III trial (NAPOLI-1) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan (nal-IRI; MM-398)+5-FU/LV	Journal of Clinical Oncology. 2017 Feb;35(4):Meeting Abstract 293.
2017-01-25	Parathyroid hormone-like hormone is a poor prognosis marker of head and neck vancer and promotes cell growth via RUNX2 regulation	Scientific Reports. 2017 Jan 25;7:Article number 41131.
2017-01-18	免疫調節細胞の作出方法、それから作出された細胞、およびその使用	JP6058802/2017-01-18
2017-01-05	Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin	Journal of Biomedical Science. 2017 Jan 5;24:Article number 2.
2017-01	Expressions of the CagA protein and CagA-signaling molecules predict H. pylori-dependence of early-stage gastric DLBCL	Blood. 2017 Jan;129(2):188-198.
2017-01	A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1alpha activation, tumorigenesis and metastasis	Nature Cell Biology. 2017 Jan;19(1):38-51.
2017-01	DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness	Oncotarget. 2017 Jan;8(2):2995-3008.
2017-01	Inhibition of the EGFR/STAT3/CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder	Clinical Cancer Research. 2017 Jan;23(2):503-513.
2017-01	Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling	Oncotarget. 2017 Jan;8(3):5603-5618.

Showing items 951-975 of 2409. (97 Page(s) Totally) << < 34 35 36 37 38 39 40 41 42 43 > >> View [10|25|50] records per page